https://pubmed.ncbi.nlm.nih.gov/38063144/
Most Fanconi anemia heterozygotes are not at increased cancer risk: A genome-first DiscovEHR cohort...
To our knowledge, this is the first and largest FA heterozygote study to use genomic ascertainment and validates well-established cancer predispositions in 5...